An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Clinical trial NCT05055024 · COMPLETED

Trial details

NCT number: NCT05055024
Sponsor: NLS Pharmaceutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy With Cataplexy Narcolepsy Narcolepsy Without Cataplexy

Start date: 2021-10-26
Primary completion: 2023-01-19
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.